Ibudilast (AV-411): a new class therapeutic candidate for neuropathic pain and opioid withdrawal syndromes
Journal Article
Overview
publication date
- July 1, 2007
has subject area
- Animal Diseases - Disease Models, Animal
- Animals
- Chemically-Induced Disorders - Opioid-Related Disorders
- Chemically-Induced Disorders - Substance Withdrawal Syndrome
- Drug Administration Schedule
- Drugs, Investigational
- Environment and Public Health - Follow-Up Studies
- Environment and Public Health - Prospective Studies
- Female
- Health Care Evaluation Mechanisms - Follow-Up Studies
- Health Care Evaluation Mechanisms - Prospective Studies
- Health Care Evaluation Mechanisms - Treatment Outcome
- Health Services Administration - Treatment Outcome
- Humans
- Investigative Techniques - Follow-Up Studies
- Investigative Techniques - Prospective Studies
- Male
- Mental Disorders - Opioid-Related Disorders
- Mental Disorders - Substance Withdrawal Syndrome
- Models, Animal - Disease Models, Animal
- Models, Biological - Disease Models, Animal
- Pain, Intractable
- Peripheral Nervous System Diseases - Neuralgia
- Pharmacological Phenomena - Dose-Response Relationship, Drug
- Prognosis
- Prognosis - Treatment Outcome
- Pyridines
- Rats
- Signs and Symptoms - Neuralgia
- Toxicological Phenomena - Dose-Response Relationship, Drug
has restriction
- closed
Date in CU Experts
- October 4, 2013 2:45 AM
Full Author List
- Ledeboer A; Hutchinson MR; Watkins LR; Johnson KW
author count
- 4
citation count
- 124
published in
Other Profiles
International Standard Serial Number (ISSN)
- 1354-3784
Electronic International Standard Serial Number (EISSN)
- 1744-7658
Digital Object Identifier (DOI)
Additional Document Info
start page
- 935
end page
- 950
volume
- 16
issue
- 7